Dr. Henrik Arnell, Karolinska University Hospital, Sweden
Henrik Arnell, MD, PhD, is a highly accomplished physician and researcher specializing in pediatric digestive diseases. Currently the Head of the Department of Pediatric Digestive Diseases at Astrid Lindgren Children’s Hospital, Stockholm, Dr. Arnell has an extensive background in gastroenterology, hepatology, and nutrition. His groundbreaking research in progressive familial intrahepatic cholestasis and his leadership roles in Swedish pediatric organizations have established him as a leading figure in the field. Dr. Arnell is widely published, with numerous papers on innovative treatments for pediatric digestive and liver diseases. His dedication to improving patient care through clinical studies and mentorship of future researchers underscores his commitment to advancing pediatric health.
Professional Profile
Scopus
Google Scholar
Summary of Suitability for the Award
Dr. Henrik Arnell, MD, PhD, demonstrates exceptional qualifications for the Research for Best Researcher Award due to his extensive contributions to pediatric gastroenterology, hepatology, and nutrition. As Head of the Department of Pediatric Digestive Diseases at the Astrid Lindgren Children’s Hospital, Stockholm, Dr. Arnell has exhibited exemplary leadership, innovative clinical approaches, and a commitment to advancing healthcare for children with complex gastrointestinal and liver conditions. His pivotal roles in clinical studies, mentorship, and international collaborations highlight his dedication to impactful research and knowledge dissemination.
Dr. Arnell’s research accomplishments are evident from his significant body of peer-reviewed publications, including articles in high-impact journals like The Lancet, Nature Communications, and Hepatology. His work spans crucial areas such as bile acid transport disorders, inflammatory bowel diseases, and liver diseases in pediatric populations.
Education
Dr. Arnell’s academic journey began with comprehensive courses in tropical medicine, clinical genetics, and molecular cell biology during the early 1990s. He obtained his PhD in Pediatrics from Karolinska Institutet, Stockholm, in 2009, with his thesis on Progressive Familial Intrahepatic Cholestasis. Over the years, he completed specialized training in pharmacological epidemiology and participated in advanced research programs in clinical epidemiology. His post-doctoral studies at Karolinska Institutet have focused on groundbreaking research in pediatric gastroenterology. With a focus on bridging academic knowledge with clinical applications, Dr. Arnell has also contributed significantly to the academic field by mentoring doctoral students and organizing national courses.
Professional Experience
Dr. Arnell has served in various capacities at Astrid Lindgren Children’s Hospital, beginning as a Consultant in 2005 and progressing to Senior Consultant and, ultimately, Head of the Department in 2014. His career highlights include leading national and international clinical studies on rare pediatric liver diseases and serving as a co-investigator and principal investigator for several impactful research projects. He has also been instrumental in organizing workshops and teaching courses in pediatric gastroenterology and hepatology. Dr. Arnell has made significant contributions as a mentor, fostering research excellence among young professionals and advancing pediatric care practices globally.
Awards and Recognitions
Dr. Arnell’s contributions to pediatric medicine have earned him widespread recognition. He has held prestigious roles such as Vice Chairman of the Swedish Pediatric Society (2018-2020) and Chairman of the Swedish Society of Pediatric Gastroenterology, Hepatology, and Nutrition (2012-2014). His dedication to education and mentorship has been acknowledged through accolades for organizing impactful national workshops and educational courses. Furthermore, Dr. Arnell’s clinical and research achievements have been celebrated in the global medical community, particularly for his work in advancing the treatment of pediatric liver diseases.
Dr. Arnell possesses advanced research skills in clinical epidemiology, pharmacological studies, and pediatric gastroenterology. His expertise lies in leading clinical trials and translational research to develop innovative treatments for pediatric liver diseases, including Progressive Familial Intrahepatic Cholestasis. He has a proven ability to collaborate across disciplines, contributing to groundbreaking studies on bile salt transport and parenteral nutrition. His strong mentorship abilities further highlight his role in fostering a new generation of researchers in pediatric health.
Publication Top Notes
- A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis
- Authors: SS Strautnieks, LN Bull, AS Knisely, SA Kocoshis, N Dahl, H Arnell, …
- Citation: 1202
- Year: 1998
- Survey of unlicensed and off-label drug use in paediatric wards in European countries
- Authors: S Conroy, I Choonara, P Impicciatore, A Mohn, H Arnell, A Rane, …
- Citation: 1089
- Year: 2000
- Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiency
- Authors: AS Knisely, SS Strautnieks, Y Meier, B Stieger, JA Byrne, BC Portmann, …
- Citation: 423
- Year: 2006
- Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families
- Authors: SS Strautnieks, JA Byrne, L Pawlikowska, D Cebecauerová, A Rayner, …
- Citation: 422
- Year: 2008
- The genetics of primary nocturnal enuresis: inheritance and suggestion of a second major gene on chromosome 12q.
- Authors: H Arnell, K Hjälmås, M Jägervall, G Läckgren, A Stenberg, B Bengtsson, …
- Citation: 249
- Year: 1997
- Integration of whole genome sequencing into a healthcare setting: high diagnostic rates across multiple clinical entities in 3219 rare disease patients
- Authors: H Stranneheim, K Lagerstedt-Robinson, M Magnusson, M Kvarnung, …
- Citation: 208
- Year: 2021
- Growth and pubertal development in Down syndrome
- Authors: H Arnell, J Gustafsson, SA Ivarsson, G Anneren
- Citation: 106
- Year: 1996
- Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial
- Authors: RJ Thompson, H Arnell, R Artan, U Baumann, PL Calvo, P Czubkowski, …
- Citation: 102
- Year: 2022
- Echocardiographic right and left ventricular measurements in male elite endurance athletes
- Authors: E Henriksen, J Landelius, L Wesslén, H Arnell, C Nyström-Rosander, …
- Citation: 97
- Year: 1996
- Genotype correlates with the natural history of severe bile salt export pump deficiency
- Authors: DBE van Wessel, RJ Thompson, E Gonzales, I Jankowska, E Sokal, …
- Citation: 96
- Year: 2020